<DOC>
	<DOCNO>NCT01886781</DOCNO>
	<brief_summary>In patient IBS , supplementation probiotic demonstrate symptomatic efficacy probiotic influence gut microflora thus improve clinical outcome , compare intervention .</brief_summary>
	<brief_title>Effect Lactobacillus Plantarum 299v Symptoms Irritable Bowel Syndrome</brief_title>
	<detailed_description>Conduct study nutrient intake gastrointestinal microbiota effect probiotic , Lactobacillus plantarum 299v irritable bowel syndrome patient .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>fulfillment Rome II criterion IBS , availability least one colonoscopy within last three year , age 18 old time screening , provision write informed consent , commitment availability throughout 12 week study period . major abdominal surgery past appendectomy , caesarean section , tubal laparoscopic cholecystectomy , abdominal wall hernia repair or/and hysterectomy , current use antibiotic , history organic intestinal disease , pregnant breastfeeding mother , chronic infectious disease like HIV tuberculosis , unable understand English Afrikaans .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>constipation diarrhea predominant</keyword>
	<keyword>mixed alternate type</keyword>
</DOC>